Vincerx Pharma Inc.

0.77
-0.32 (-29.36%)
At close: Mar 03, 2025, 3:59 PM
0.79
3.16%
After-hours: Mar 03, 2025, 05:59 PM EST

Vincerx Pharma Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 915K 939K 340K 173K 173K
Gross Profit -915K -939K -340K -173K -173K
Operating Income -42.61M -73.57M -62.66M -10.71M -45K
Interest Income 1.25M 664K n/a 54.27K 54.27K
Pretax Income -40.16M -65.37M -39.31M -10.72M -45K
Net Income -40.16M -57.16M -15.61M -10.73M -45K
Selling & General & Admin 13.64M 18.95M 22.57M 3.6M 45K
Research & Development 28.06M 52.15M 40.08M 7.12M n/a
Other Expenses n/a 1.24M -8K -8K n/a
Operating Expenses 42.61M 71.11M 62.66M 10.71M 45K
Interest Expense n/a n/a n/a 8K n/a
Selling & Marketing Expenses n/a n/a n/a n/a 44.95K
Cost & Expenses 42.61M 71.11M 62.66M 10.71M 45K
Income Tax n/a -8.21M -23.7M 8K -54
Shares Outstanding (Basic) 21.3M 21.03M 17.18M 13.98M 5.2M
Shares Outstanding (Diluted) 21.3M 21.03M 17.18M 13.98M 5.2M
EPS (Basic) -1.89 -2.72 -0.91 -0.77 -0.01
EPS (Diluted) -1.89 -2.72 -0.91 -0.77 -0.01
EBITDA -42.61M -68.67M -62.66M -10.71M 9K
Depreciation & Amortization 52K 939K 340K 5.71M 54K